Q3 2017

Filed Nov 15, 2017 · 10-Q · 46 days after period end · 0001654954-17-010747

Q3 2017 · 10-Q

Revenue

$27.22K

+45.8% vs Q3 2016

Net Income

-$279.79K

N/M vs Q3 2016

EPS Diluted

$0.00

— vs Q3 2016

Operating Income-$234,420N/M

Operating Cash Flow

Same quarter

Metric	Q3 2017	Q3 2016	Q3 2015	Q3 2014
Revenue	$27.22K	$18.67K	$0.00	$0.00
Net Income	-$279.79K	-$1.12M	-$348.52K	-$239.04K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR